» Articles » PMID: 28894514

Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study

Overview
Specialty Gastroenterology
Date 2017 Sep 13
PMID 28894514
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Prevalence of gastroesophageal reflux disease (GERD) is increasing worldwide. We aimed to estimate the prevalence of GERD in Pars Cohort Study (PCS) and to find its correlates. METHODS We used the baseline data from PCS. PCS was conducted in the district of Valashahr in Fars province in southern Iran from 2012 to 2014. 9264 inhabitants who were 40-75 years old, and agreed to participate were enrolled. Data were collected by a structured questionnaire and simple physical examination of all participants. RESULTS Generally, 58.50% (95% CI 57.49 - 59.51) of the participants had GERD and 25.10% (95% CI 24.22 - 25.99) experienced it at least weekly. Approximately, 32.0%, 52.0%, and 24.4% of the participants reported heart burn sensation, regurgitation, and both symptoms, respectively. Being female (OR: 1.45, 95% CI 1.27 - 1.65), being older (OR: 1.20, 95% CI 1.06 - 1.36), being divorced/ widowed/separated (OR: 1.38, 95% CI 1.01 - 1.91), and lower education (OR: 1.43, 95% CI 1.02 - 2.03) were associated with frequent GERD. CONCLUSION GERD is common in PCS and its prevalence is close to that in western countries. Being female, higher age, being divorced/widowed/separated, lower education, history of hypertension, anxiety, insomnia, and non-cigarette tobacco smoking were associated with frequent GERD. We are going to investigate the causal relationship between these risk factors and GERD in the next stages of PCS.

Citing Articles

Prevalence and risk factors of gastroesophageal reflux disease symptoms in Mazandaran, North of Iran: A Tabari cohort study.

Maleki I, Borhani S, Moosazadeh M, Alizadeh-Navaei R Caspian J Intern Med. 2024; 15(2):280-286.

PMID: 38807738 PMC: 11129062. DOI: 10.22088/cjim.15.2.280.


Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study.

Akbari M, Kamalipour A, Pakroo M, Mesgarpour B, Poustchi H, Mohammadi Z Arch Iran Med. 2023; 26(3):156-165.

PMID: 37543938 PMC: 10685724. DOI: 10.34172/aim.2023.24.


Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis.

Karimian M, Nourmohammadi H, Salamati M, Ahmadi M, Kazemi F, Azami M BMC Gastroenterol. 2020; 20(1):297.

PMID: 32928126 PMC: 7488684. DOI: 10.1186/s12876-020-01417-6.


Socioeconomic Inequalities in Gastroesophageal Reflux Disorder: Results from an Iranian Cohort Study.

Farjam M, Sharafi M, Bahramali E, Rezaei S, Hassanzadeh J, Rezaeian S Middle East J Dig Dis. 2018; 10(3):180-187.

PMID: 30186582 PMC: 6119839. DOI: 10.15171/mejdd.2018.108.

References
1.
Tan V, Wong B, Wong W, Leung W, Tong D, Yuen M . Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. J Clin Gastroenterol. 2015; 50(1):e1-7. DOI: 10.1097/MCG.0000000000000304. View

2.
Wang H, Leena K, Plymoth A, Hergens M, Yin L, Shenoy K . Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India. BMC Gastroenterol. 2016; 16:36. PMC: 4791779. DOI: 10.1186/s12876-016-0452-1. View

3.
Bor S, Mandiracioglu A, Kitapcioglu G, Caymaz-Bor C, Gilbert R . Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol. 2005; 100(4):759-65. DOI: 10.1111/j.1572-0241.2005.41065.x. View

4.
Masoumi S, Khademolhosseini F, Mehrabani D, Moradi F, Mostaghni A, Zare N . Correlation of quality of life with gastroesophageal reflux disease amongst Qashqai nomads in Iran. Arch Iran Med. 2012; 15(12):747-50. DOI: 0121512/AIM.005. View

5.
Kessing B, Bredenoord A, Saleh C, Smout A . Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2014; 13(6):1089-95.e1. DOI: 10.1016/j.cgh.2014.11.034. View